Bullman v. AstraZeneca LP et al
Marvin Bullman |
Merck Sharp & Dohme Corporation, AstraZeneca LP, AstraZeneca Pharmaceuticals, LP, The Procter & Gamble Company and The Procter & Gamble Manufacturing Company |
1:2020cv00865 |
October 30, 2020 |
US District Court for the Southern District of Ohio |
Douglas R Cole |
Personal Inj. Prod. Liability |
28 U.S.C. ยง 1332 |
Defendant |
Docket Report
This docket was last retrieved on December 3, 2020. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 8 CONDITIONAL TRANSFER ORDER (CTO-30): Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on MDL this action is transferred to the District of New Jersey. Signed by the Clerk of the Panel on 12/1/2020; certified by the Clerk's Office District of New Jersey on 12/1/2020. (er) |
Filing 7 CONDITIONAL TRANSFER ORDER (CTO-30): This order does not become effective until it is filed in the Office of the Clerk of the USDC for the District of New Jersey. Signed by the Clerk of the Panel on 12/1/2020. (er) |
***Case transferred from Ohio Southern has been opened in District of New Jersey [LIVE] as case 2:20-cv-17913, filed 12/03/2020. (er) |
Case transferred to District of New Jersey. Case file and docket sheet sent Electronically. (er) |
Filing 6 ANSWER to #4 Complaint with Jury Demand originally filed 8/2/2019 in Hamilton County Court of Common Pleas (Case No. A1902701) by Merck Sharp & Dohme Corporation. (eh) |
Filing 5 ANSWER to #4 Complaint with Jury Demand originally filed 8/2/2019 in Hamilton County Court of Common Pleas (Case No. A1902701) by AstraZeneca LP, AstraZeneca Pharmaceuticals, LP. (eh) |
Filing 4 COMPLAINT with JURY DEMAND originally filed 5/31/2019 in Hamilton County Court of Common Pleas (Case No. A1902701) by Marvin Bullman against All Defendants. (eh) |
If this case is referred, it will be to Magistrate Judge Karen L. Litkovitz. (eh) |
Filing 3 Corporate Disclosure Statement by Defendants Merck Sharp & Dohme Corporation, Merck Sharp & Dohme Corporation identifying Corporate Parent Merck Sharp & Dohme Corporation for Merck Sharp & Dohme Corporation.. (Anderson, Daniel) |
Filing 2 Corporate Disclosure Statement by Defendants AstraZeneca LP, AstraZeneca Pharmaceuticals, LP, identifying Corporate Parent AstraZeneca Pharmaceuticals PLC for AstraZeneca Pharmaceuticals, LP and AstraZeneca LP. (Anderson, Daniel) Modified docket text on 11/4/2020 (kh). |
Filing 1 NOTICE OF REMOVAL from hamilton common pleas, case number A 1902701 ( Filing fee $ 400 paid - receipt number: 0648-7732454), filed by Merck Sharp & Dohme Corporation, AstraZeneca Pharmaceuticals, LP, AstraZeneca LP. (Attachments: #1 Exhibit, #2 Civil Cover Sheet, #3 Supplemental Civil Cover Sheet) (Anderson, Daniel) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Ohio Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.